Table 3.
Comparison of lab data between gallbladder abnormality (GBA) and non-GBA in Kawasaki disease before IVIG therapy.
| Group A (non-GBA, N = 61) | Group B (GBA, B = 16) | P value | |
|---|---|---|---|
| WBC cell (/mm3) | 13854 ± 5005 | 12519 ± 4465 | 0.335 |
| Hemoglobin (g/dL) | 11.0 ± 1.33 | 11.0 ± 1.23 | 0.948 |
| Platelet (×104/mm3) | 35.4 ± 13.0 | 30.4 ± 9.03 | 0.156 |
| Neutrophil (%) | 61.9 ± 15.2 | 76.8 ± 10.2 | 0.001* |
| Lymphocyte (%) | 27.4 ± 14.4 | 14.8 ± 9.10 | 0.001* |
| Eosinophil (%) | 2.62 ± 2.82 | 1.39 ± 2.01 | 0.108 |
| Monocyte (%) | 6.51 ± 3.51 | 5.86 ± 2.84 | 0.497 |
| C-reactive protein (mg/L) | 94.6 ± 77.4 | 143.9 ± 78.2 | 0.027* |
| GOT (U/L) | 58.8 ± 72.9 | 78.3 ± 80.6 | 0.358 |
| GPT (U/L) | 81.2 ± 100 | 150.9 ± 133.5 | 0.028* |
*P < 0.05.